"The FDA approval of Wegovy pill -- the first oral GLP-1 for adults with obesity and overweight with weight-related medical problems -- has the potential to impact millions of Americans," Dave Moore, executive vice president of Novo Nordisk Inc.'s U.S

You should contact your GP or seek specialist referral if you are experiencing: Unexplained weight gain or difficulty losing weight despite lifestyle changes Symptoms that may suggest growth hormone deficiency , such as persistent fatigue, reduced muscle mass, increased abdominal fat, or low mood formal biochemical testing is required before any treatment is initiated Poorly controlled blood glucose or a new diagnosis of type 2 diabetes Interest in weight-management medicines , to discuss licensed options available through NHS or regulated private pathways access to weight-management pharmacotherapy on the NHS is typically via specialist weight management services, subject to local eligibility criteria Seek urgent medical attention via NHS 111 or, if necessary, 999 if you experience severe or persistent abdominal pain (which may indicate pancreatitis), signs of a serious allergic reaction, chest pain or palpitations, or symptoms of diabetic ketoacidosis (extreme thirst, frequent urination, confusion, or vomiting)

This could be something to consider to save money on the front end of your subscription
It is worth noting that a March 2026 study by Langer and colleagues published in Cell Reports Medicine found that weight loss on GLP-1 medications does not result in a disproportionate loss of muscle mass or function, particularly when patients maintain resistance training
10.1099/mic.0.000080 Microbiology 88 WendischV
The same 5mg vial mixed with 2.5mL yields a 2mg/mL solution, doubling the peptide concentration per unit volume